Somatic mutations in DROSHA and DICER1 impair microRNA biogenesis through distinct mechanisms in Wilms tumours

Dinesh Rakheja, Kenneth S. Chen, Yangjian Liu, Abhay A. Shukla, Vanessa Schmid, Tsung-Cheng Chang, Shama Khokhar, Jonathan E. Wickiser, Nitin J. Karandikar, James S. Malter, Joshua T. Mendell () and James F. Amatruda ()
Additional contact information
Dinesh Rakheja: University of Texas Southwestern Medical Center
Kenneth S. Chen: University of Texas Southwestern Medical Center
Yangjian Liu: University of Texas Southwestern Medical Center
Abhay A. Shukla: University of Texas Southwestern Medical Center
Vanessa Schmid: Eugene McDermott Center for Human Growth and Development, University of Texas Southwestern Medical Center
Tsung-Cheng Chang: University of Texas Southwestern Medical Center
Shama Khokhar: Children’s Medical Center
Jonathan E. Wickiser: University of Texas Southwestern Medical Center
Nitin J. Karandikar: University of Texas Southwestern Medical Center
James S. Malter: University of Texas Southwestern Medical Center
Joshua T. Mendell: University of Texas Southwestern Medical Center
James F. Amatruda: University of Texas Southwestern Medical Center

Nature Communications, 2014, vol. 5, issue 1, 1-11

Abstract: Abstract Wilms tumour is the most common childhood kidney cancer. Here we report the whole-exome sequencing of 44 Wilms tumours, identifying missense mutations in the microRNA (miRNA)-processing enzymes DROSHA and DICER1, and novel mutations in MYCN, SMARCA4 and ARID1A. Examination of tumour miRNA expression, in vitro processing assays and genomic editing in human cells demonstrates that DICER1 and DROSHA mutations influence miRNA processing through distinct mechanisms. DICER1 RNase IIIB mutations preferentially impair processing of miRNAs deriving from the 5′-arm of pre-miRNA hairpins, while DROSHA RNase IIIB mutations globally inhibit miRNA biogenesis through a dominant-negative mechanism. Both DROSHA and DICER1 mutations impair expression of tumour-suppressing miRNAs, including the let-7 family, important regulators of MYCN, LIN28 and other Wilms tumour oncogenes. These results provide new insights into the mechanisms through which mutations in miRNA biogenesis components reprogramme miRNA expression in human cancer and suggest that these defects define a distinct subclass of Wilms tumours.

Date: 2014
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/ncomms5802 Abstract (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:natcom:v:5:y:2014:i:1:d:10.1038_ncomms5802

Ordering information: This journal article can be ordered from
https://www.nature.com/ncomms/

DOI: 10.1038/ncomms5802

Access Statistics for this article

Nature Communications is currently edited by Nathalie Le Bot, Enda Bergin and Fiona Gillespie

More articles in Nature Communications from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().